Patents Assigned to Brainsonix Corporation
  • Patent number: 12257446
    Abstract: Embodiments provide for systems and methods for modulating activity of a live neuronal circuit within the brain of a mammal. In one example, a method comprises applying a focused microwave pulse to a focal spot corresponding to the live neuronal circuit, while simultaneously monitoring a brain image produced by a brain imaging system. In this way, the focused microwave pulse may be used to transiently modulate the function of the live neuronal circuit, as guided by anatomical and functional information provided via the brain imaging system, useful for both research purposes and for treating psychiatric, neurological and neuroendocrine disorders.
    Type: Grant
    Filed: August 24, 2021
    Date of Patent: March 25, 2025
    Assignee: BRAINSONIX CORPORATION
    Inventors: Alexander Bystritsky, Alexander David Lapidus
  • Patent number: 12201856
    Abstract: Structures and methods for ultrasound treatment of neurological and psychological conditions, using energy levels which do not cause heating or cavitation. The structure includes an outer casing comprising a first material, and a disk positioned inside the outer casing. The disk comprises a second material that differs in composition from the first material and that has a higher acoustic attenuation of ultrasound energy than the first material.
    Type: Grant
    Filed: February 25, 2022
    Date of Patent: January 21, 2025
    Assignee: BrainSonix Corporation
    Inventors: Samantha F. Schafer, Mark E. Schafer
  • Patent number: 11766576
    Abstract: Ultrasonic energy is used for treating degenerative dementia. A focal point of an ultrasonic transducer beam is directed at a target area of the brain to promote removal of substances that accumulate in the interstitial pathways that are at least partially responsible for the degenerative dementia. In one example, the target area of the brain may comprise the hippocampus and the degenerative dementia may be Alzheimer's disease. The ultrasonic beam may stimulate brain tissue at a frequency that corresponds to a naturally occurring deep sleep burst frequency of neurons and subsequent astrocyte activation patterns that drive a convective process responsible for brain solute disposal. For example, the transducer may generate a burst frequency of between 1-4 hertz to stimulate deep sleep brain functions that help remove amyloid plaque.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: September 26, 2023
    Assignee: Brainsonix Corporation
    Inventors: Shelly Jordan, Mark Evan Schafer, Alex Korb, Walter William Wurster
  • Patent number: 11759661
    Abstract: Embodiments herein provide an ultrasonic treatment device that includes a transducer holder to hold an ultrasonic transducer. The transducer holder includes multiple mounting positions for the ultrasonic transducer to enable the transducer to be held by the transducer holder at different angles. For example, in some embodiments, the transducer holder may include multiple mounting elements on an interior surface of the transducer holder. The mounting elements may be, for example, ridges or grooves on the interior surface. The transducer may include and/or be provided with one or more locking elements that interact with the mounting elements of the transducer holder to hold the transducer within the transducer holder. Other embodiments may be described and claimed.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: September 19, 2023
    Assignee: BRAINSONIX CORPORATION
    Inventors: Mark Evan Schafer, Alexander Bystritsky, Christopher H. Scholl, Joseph Jackson
  • Patent number: 11311748
    Abstract: A stereotactic frame includes a vertical column that extends up from a base. A first laterally extending support arm extends from a first side of the column and a second laterally extending support arm extends from a second side of the column. One of the first or second support arms may include a transducer assembly. The transducer assembly may move a focal point of the transducer in different lateral and longitudinal horizontal positions and different vertical positions. The transducer assembly also may move the focal point of the transducer beam into different pivoting angled positions. The stereotactic frame applies repeatable ultrasonic energy to targets inside a patient without using invasive attachment procedures and without having to repeatedly use expensive magnetic resonance imaging (MRI) machines.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: April 26, 2022
    Assignee: BRAINSONIX CORPORATION
    Inventor: Walter William Wurster
  • Publication number: 20220054853
    Abstract: Embodiments provide for systems and methods for modulating activity of a live neuronal circuit within the brain of a mammal. In one example, a method comprises applying a focused microwave pulse to a focal spot corresponding to the live neuronal circuit, while simultaneously monitoring a brain image produced by a brain imaging system. In this way, the focused microwave pulse may be used to transiently modulate the function of the live neuronal circuit, as guided by anatomical and functional information provided via the brain imaging system, useful for both research purposes and for treating psychiatric, neurological and neuroendocrine disorders.
    Type: Application
    Filed: August 24, 2021
    Publication date: February 24, 2022
    Applicant: BRAINSONIX CORPORATION
    Inventors: Alexander BYSTRITSKY, Alexander David LAPIDUS
  • Publication number: 20210361975
    Abstract: Embodiments herein provide an ultrasonic treatment device that includes a transducer holder to hold an ultrasonic transducer. The transducer holder includes multiple mounting positions for the ultrasonic transducer to enable the transducer to be held by the transducer holder at different angles. For example, in some embodiments, the transducer holder may include multiple mounting elements on an interior surface of the transducer holder. The mounting elements may be, for example, ridges or grooves on the interior surface. The transducer may include and/or be provided with one or more locking elements that interact with the mounting elements of the transducer holder to hold the transducer within the transducer holder. Other embodiments may be described and claimed.
    Type: Application
    Filed: May 20, 2020
    Publication date: November 25, 2021
    Applicant: BRAINSONIX CORPORATION
    Inventors: Mark Evan SCHAFER, Alexander BYSTRITSKY, Christopher H. Scholl, Joseph JACKSON
  • Patent number: 10974078
    Abstract: Ultrasonic energy is used for treating degenerative dementia. A focal point of an ultrasonic transducer beam is directed at a target area of the brain to promote removal of substances that accumulate in the interstitial pathways that are at least partially responsible for the degenerative dementia. In one example, the target area of the brain may comprise the hippocampus and the degenerative dementia may be Alzheimer's disease. The ultrasonic beam may stimulate brain tissue at a frequency that corresponds to a naturally occurring deep sleep burst frequency of neurons and subsequent astrocyte activation patterns that drive a convective process responsible for brain solute disposal. For example, the transducer may generate a burst frequency of between 1-4 hertz to stimulate deep sleep brain functions that help remove amyloid plaque.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: April 13, 2021
    Assignee: BRAINSONIX CORPORATION
    Inventors: Shelly Jordan, Mark Evan Schafer, Alex Korb, Walter William Wurster
  • Patent number: 10792519
    Abstract: A focused ultrasonic transducer navigation system attaches to a patient and includes a housing that contains an ultrasonic device. An alignment system moves the housing, and moves the ultrasonic device within the housing, so a focal point of ultrasonic energy from the ultrasonic device is aligned in x, y, and z planes with a target location in the patient. The alignment system realigns the focal point of the ultrasonic device with the same patient target location over multiple therapy sessions eliminating repeated use of an MRI system for repeatedly realigning the ultrasonic device.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: October 6, 2020
    Assignee: BRAINSONIX CORPORATION
    Inventors: Walter William Wurster, Michael Allen Gustafson, Elaine Patrice Pelletier, Richard Alan Waltz
  • Publication number: 20200121958
    Abstract: A stereotactic frame includes a vertical column that extends up from a base. A first laterally extending support arm extends from a first side of the column and a second laterally extending support arm extends from a second side of the column. One of the first or second support arms may include a transducer assembly. The transducer assembly may move a focal point of the transducer in different lateral and longitudinal horizontal positions and different vertical positions. The transducer assembly also may move the focal point of the transducer beam into different pivoting angled positions. The stereotactic frame applies repeatable ultrasonic energy to targets inside a patient without using invasive attachment procedures and without having to repeatedly use expensive magnetic resonance imaging (MRI) machines.
    Type: Application
    Filed: December 20, 2019
    Publication date: April 23, 2020
    Applicant: BRAINSONIX CORPORATION
    Inventor: Walter William WURSTER
  • Patent number: 10512794
    Abstract: A stereotactic frame includes a vertical column that extends up from a base. A first laterally extending support arm extends from a first side of the column and a second laterally extending support arm extends from a second side of the column. One of the first or second support arms may include a transducer assembly. The transducer assembly may move a focal point of the transducer in different lateral and longitudinal horizontal positions and different vertical positions. The transducer assembly also may move the focal point of the transducer beam into different pivoting angled positions. The stereotactic frame applies repeatable ultrasonic energy to targets inside a patient without using invasive attachment procedures and without having to repeatedly use expensive magnetic resonance imaging (MRI) machines.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: December 24, 2019
    Assignee: BRAINSONIX CORPORATION
    Inventor: Walter William Wurster
  • Publication number: 20180169443
    Abstract: A stereotactic frame includes a vertical column that extends up from a base. A first laterally extending support arm extends from a first side of the column and a second laterally extending support arm extends from a second side of the column. One of the first or second support arms may include a transducer assembly. The transducer assembly may move a focal point of the transducer in different lateral and longitudinal horizontal positions and different vertical positions. The transducer assembly also may move the focal point of the transducer beam into different pivoting angled positions. The stereotactic frame applies repeatable ultrasonic energy to targets inside a patient without using invasive attachment procedures and without having to repeatedly use expensive magnetic resonance imaging (MRI) machines.
    Type: Application
    Filed: December 16, 2016
    Publication date: June 21, 2018
    Applicant: BRAINSONIX CORPORATION
    Inventor: Walter William WURSTER
  • Patent number: 9630029
    Abstract: A focused ultrasonic transducer navigation system attaches to a patient and includes a housing that contains an ultrasonic device. An alignment system moves the housing, and moves the ultrasonic device within the housing, so a focal point of ultrasonic energy from the ultrasonic device is aligned in x, y, and z planes with a target location in the patient. The alignment system realigns the focal point of the ultrasonic device with the same patient target location over multiple therapy sessions eliminating repeated use of an MRI system for repeatedly realigning the ultrasonic device.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: April 25, 2017
    Assignee: BRAINSONIX CORPORATION
    Inventors: Walter William Wurster, Michael Allen Gustafson, Elaine Patrice Pelletier, Richard Alan Waltz
  • Patent number: 9061133
    Abstract: A focused ultrasonic transducer navigation system attaches to a patient and includes a housing that contains an ultrasonic device. An alignment system moves the housing, and moves the ultrasonic device within the housing, so a focal point of ultrasonic energy from the ultrasonic device is aligned in x, y, and z planes with a target location in the patient. The alignment system realigns the focal point of the ultrasonic device with the same patient target location over multiple therapy sessions eliminating repeated use of an MRI system for repeatedly realigning the ultrasonic device.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: June 23, 2015
    Assignee: BRAINSONIX CORPORATION
    Inventors: Walter William Wurster, Michael Allen Gustafson, Elaine Patrice Pelletier, Richard Alan Waltz
  • Publication number: 20140378874
    Abstract: A focused ultrasonic transducer navigation system attaches to a patient and includes a housing that contains an ultrasonic device. An alignment system moves the housing, and moves the ultrasonic device within the housing, so a focal point of ultrasonic energy from the ultrasonic device is aligned in x, y, and z planes with a target location in the patient. The alignment system realigns the focal point of the ultrasonic device with the same patient target location over multiple therapy sessions eliminating repeated use of an MRI system for repeatedly realigning the ultrasonic device.
    Type: Application
    Filed: September 5, 2014
    Publication date: December 25, 2014
    Applicant: Brainsonix Corporation
    Inventors: Walter William Wurster, Michael Allen Gustafson, Elaine Patrice Pelletier, Richard Alan Waltz
  • Publication number: 20140188011
    Abstract: A focused ultrasonic transducer navigation system attaches to a patient and includes a housing that contains an ultrasonic device. An alignment system moves the housing, and moves the ultrasonic device within the housing, so a focal point of ultrasonic energy from the ultrasonic device is aligned in x, y, and z planes with a target location in the patient. The alignment system realigns the focal point of the ultrasonic device with the same patient target location over multiple therapy sessions eliminating repeated use of an MRI system for repeatedly realigning the ultrasonic device.
    Type: Application
    Filed: December 27, 2012
    Publication date: July 3, 2014
    Applicant: Brainsonix Corporation
    Inventors: Walter William Wurster, Michael Allen Gustafson, Elaine Patrice Pelletier, Richard Alan Waltz
  • Patent number: 8086296
    Abstract: Disclosed herein are methods for modifying electrical currents in brain circuits through the simultaneous use of focused ultrasound pulse (FUP) and an existing brain-imaging system, such as a functional magnetic resonance imaging (fMRI) system. The methods are used for research, treatment and diagnosis of psychiatric, neurological, and neuroendocrine disorders whose biological mechanisms include brain circuits. The methods include the simultaneous steps of applying FUP to a live neuronal circuit within a brain and monitoring a brain image produced by a brain imaging system during the application of FUP.
    Type: Grant
    Filed: August 27, 2007
    Date of Patent: December 27, 2011
    Assignee: Brainsonix Corporation
    Inventor: Alexander Bystritsky
  • Patent number: D946153
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: March 15, 2022
    Assignee: BRAINSONIX CORPORATION
    Inventors: Mark Evan Schafer, Christopher H. Scholl, Joseph Jackson